75 results match your criteria: "BreastCheck & Cork University Hospital[Affiliation]"
Eur J Public Health
December 2024
National Cancer Registry Ireland, Cork, Ireland.
Breast cancer screening programmes can lead to better disease outcomes, but women from deprived backgrounds are less likely to participate and more likely to present with late-stage cancer. This study aimed to explore associations between deprivation and breast cancer screening outcomes in Ireland during 2009-2018. Data on all female breast cancer cases diagnosed in Ireland during 2009-2018 were extracted from the National Cancer Registry Ireland.
View Article and Find Full Text PDFJ Med Screen
September 2024
BreastCheck, National Screening Service, Ireland.
Objective: Many population-based breast screening programmes temporarily suspended routine screening following the COVID-19 pandemic onset. This study aimed to describe screening mammography utilisation and the pattern of screen-detected breast cancer diagnoses following COVID-19-related screening disruptions in Ireland.
Methods: Using anonymous aggregate data from women invited for routine screening, three time periods were examined: (1) January-December 2019, (2) January-December 2020, and (3) January-December 2021.
Eur J Radiol Open
December 2023
School of Population Health, RCSI University of Medicine and Health Sciences, Beaux Lane House, Mercer St. Lower, Dublin 2, Ireland.
Introduction: High mammographic breast density (MBD) is an independent breast cancer risk factor. In organised breast screening settings, discussions are ongoing regarding the optimal clinical role of MBD to help guide screening decisions. The aim of this scoping review was to provide an overview of current practices incorporating MBD within population-based breast screening programmes and from professional organisations internationally.
View Article and Find Full Text PDFCancers (Basel)
February 2023
Department of Pathology, Bács-Kiskun County Teaching Hospital, 6000 Kecskemét, Hungary.
Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps in determining the number of observers that would be sufficient for the reliable estimation of inter-observer agreement of TIL categorisation.
View Article and Find Full Text PDFActa Oncol
November 2022
School of Medicine, Trinity College Dublin, Dublin, Ireland.
Background: BreastCheck is Ireland's breast screening service which offers biennial mammograms to women aged 50-69. Practicing regular breast self-examination (BSE) enhances women's awareness and increases their perception of their susceptibility to the risk of breast cancer, possibly increasing their likelihood of attending a screening programme which reduces breast cancer mortality. Research is needed to identify the promotors and barriers to both attending breast cancer screening and practicing BSE.
View Article and Find Full Text PDFArch Pathol Lab Med
November 2022
Cambridge Experimental Cancer Medicine Centre (ECMR), Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Context.—: The International Collaboration on Cancer Reporting (ICCR), supported by major pathology and cancer organizations, aims at the standardization of evidence-based pathology reporting of different types of cancers, with the inclusion of all parameters deemed to be relevant for best patient care and future data collection. Lymph node metastasis is one of the most important prognostic factors in breast cancer.
View Article and Find Full Text PDFJ Med Screen
March 2023
Programme Evaluation Unit, National Screening Service, Dublin, Ireland.
Objective And Setting: Accurate monitoring of interval cancers is important both for quality improvement and education and is a key parameter of breast screening quality assurance. Issues in relation to communication regarding interval cervical cancer in the Irish cervical screening programme were found, prompting interval cancer process review in all cancer screening programmes. An international survey to examine international consensus on interval breast cancer audit processes was conducted to inform Irish processes.
View Article and Find Full Text PDFPathobiology
October 2022
Discipline of Pathology, School of Medicine, Lambe Institute for Translational Research, National University of Ireland, Galway, Ireland.
The management of patients with breast cancer (BC) relies on the assessment of a defined set of well-established prognostic and predictive markers. Despite overlap, prognostic markers are used to assess the risk of recurrence and the likely benefit of systemic therapy, whereas predictive markers are used to determine the type of systemic therapy to be offered to an individual patient. In this review, we provide an update and present some challenges in the assessment of the main BC-specific molecular predictive markers, namely hormone receptors (oestrogen receptor [ER] and progesterone receptor [PR]), human epidermal growth factor receptor 2 (HER2), and KI67.
View Article and Find Full Text PDFJ Med Screen
September 2022
BreastCheck, 155307National Screening Service, Dublin, Ireland.
Objectives: The purpose of this study was to evaluate the grade distribution of screen-detected ductal carcinoma in situ (DCIS) diagnosed in Ireland, in the context of the clinical trials currently underway to determine if active surveillance is a feasible management option for low-risk DCIS.
Setting: BreastCheck is the national breast screening programme in Ireland, offering screening to women aged 50 to 69 every two years.
Methods: This study was a secondary analysis of data collected by BreastCheck on all screen-detected DCIS diagnosed in the 12 years of nationwide screening.
Phys Med Biol
February 2022
Mater Misericordiae University Hospital, Dublin, Ireland.
. Mammogram image quality in European breast screening systems is defined by threshold gold thickness () assessment of the CDMAM contrast-detail phantom. Previous studies have outlined several limitations of the phantom including expense, number of images required and inter-phantom manufacturing variability.
View Article and Find Full Text PDFRadiography (Lond)
May 2022
Medical Imaging and Radiation Therapy, School of Medicine, UG Assert, Brookfield Health Sciences, University College Cork, T12 AK54, Ireland. Electronic address:
Introduction: Breast cancer is one of the most prevalent cancers in women, however Irish Traveller women have lower breast screening rates than that of the general population. This work aims to address the gap in knowledge of Irish Traveller womens' perceptions of breast screening and the perceived barriers and enablers to attendance.
Methods: This phenomenological qualitative study involves interviews with Irish Traveller women and Health Care Professionals and discusses the incentives and barriers to attending breast screening mammography in Ireland.
Cancers (Basel)
November 2021
Pathology & Cytology Dalarna, Falun County Hospital, 791 82 Falun, Sweden.
Triple-negative breast cancers (TNBC), as a group of tumours, have a worse prognosis than stage-matched non-TNBC and lack the benefits of routinely available targeted therapy. However, TNBC is a heterogeneous group of neoplasms, which includes some special type carcinomas with a relatively indolent course. This review on behalf of the European Working Group for Breast Screening Pathology reviews the literature on the special histological types of BC that are reported to have a triple negative phenotype and indolent behaviour.
View Article and Find Full Text PDFCancers (Basel)
August 2021
Discipline of Pathology, Lambe Institute for Translational Research, School of Medicine, National University of Ireland Galway, H91 TK33 Galway, Ireland.
Stromal tumour infiltrating lymphocytes (sTILs) are a strong prognostic marker in triple negative breast cancer (TNBC). Consistency scoring sTILs is good and was excellent when an internet-based scoring aid developed by the TIL-WG was used to score cases in a reproducibility study. This study aimed to evaluate the reproducibility of sTILs assessment using this scoring aid in cases from routine practice and to explore the potential of the tool to overcome variability in scoring.
View Article and Find Full Text PDFVirchows Arch
January 2022
Histopathology, BreastCheck, Irish National Breast Screening Programme and St. Vincent's University Hospital, Dublin, Ireland.
Spindle cell lesions of the breast comprise a heterogeneous group of lesions, ranging from reactive and benign processes to aggressive malignant tumours. Despite their rarity, they attract the attention of breast pathologists due to their overlapping morphological features and diagnostic challenges, particularly on core needle biopsy (CNB) specimens. Pathologists should recognise the wide range of differential diagnoses and be familiar with the diverse morphological appearances of these lesions to make an accurate diagnosis and to suggest proper management of the patients.
View Article and Find Full Text PDFEur J Radiol
July 2021
Dept of Physics and Earth Sciences, University of Ferrara, via Saragat 1, 44122 Ferrara, Italy.
Purpose: The aim of this work was to compare, in a clinical study, digital mammography and synthetic mammography imaging by evaluating the contrast in microcalcifications of different sizes.
Methods: A retrospective review of microcalcifications from 46 patients was undertaken. A Hologic 3-Dimensions mammography system and a HD Combo protocol was used for simultaneous acquisition of the digital and synthetic images.
Eur J Radiol
May 2021
Department of Epidemiology and Public Health, University College Cork, Cork, Ireland.
Introduction: Interval breast cancers occur following a negative breast screening mammogram and before the next scheduled appointment within screening programmes. Radiological review classifies them as cancers that develop between screens, cancers with no obvious malignant abnormalities on prior screens or cancers not detected at screening. This study aimed to systematically review published literature on the occurrence of open disclosure following interval cancer radiological reviews by breast screening programmes internationally in a retrospective setting and examine methodologies used for radiological reviews for the purposes of disclosure.
View Article and Find Full Text PDFSurg Innov
August 2021
Department of Breast Surgery, Cork University Hospital, Ireland.
Breast screening has decreased morbidity and mortality due to detection of early, non-palpable breast cancers. One of the challenges of performing breast-conserving surgery on non-palpable breast tumours is accurate localization of the cancer. We aimed to perform a feasibility study to examine the outcomes associated with the introduction of a novel radiofrequency identification system (RFID) called LOCalizer as an alternative to traditional wire-guided localization.
View Article and Find Full Text PDFBreast Cancer Res Treat
October 2020
Department of Surgery, Breastcheck Eccles Unit, Eccles St, Dublin 7, Ireland.
Purpose: Radial scars and complex sclerosing lesions of the breast are part of a group of "indeterminate" breast lesions, which are excised due to risk of coexistent carcinoma. The aim of this study was to assess rate of upgrade of these lesions to invasive and in situ carcinoma and to quantify the risk of development of subsequent cancer in women diagnosed with these lesions.
Methods: A retrospective review of a prospectively maintained breast screening database was performed.
Surg J (N Y)
April 2020
Department of Breast Surgery, University Hospital Galway, Galway, Ireland.
Routine utilization of multigene assays to inform operative decision-making in early breast cancer (EBC) treatment is yet to be established. In this pilot study, we sought to establish the potential benefits of surgical intervention in EBC based on recurrence risk quantification using the Oncotype DX (ODX) assay. Consecutive ODX tests performed over a 9-year period from October 2007 to May 2016 were evaluated.
View Article and Find Full Text PDFHealth Qual Life Outcomes
June 2020
Department of Health Research Methodology, Evidence and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, 1280 Main Street West, Hamilton, ON, L8N 4K1, Canada.
Background: During healthcare guideline development, panel members often have implicit, different definitions of health outcomes that can lead to misunderstandings about how important these outcomes are and how to balance benefits and harms. McMaster GRADE Centre researchers developed 'health outcome descriptors' for standardizing descriptions of health outcomes and overcoming these problems to support the European Commission Initiative on Breast Cancer (ECIBC) Guideline Development Group (GDG). We aimed to determine which aspects of the development, content, and use of health outcome descriptors were valuable to guideline developers.
View Article and Find Full Text PDFIr J Med Sci
November 2020
Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.
Background: Breast cancer is the most common cancer in women. Beaumont Hospital is a nationally designated symptomatic breast cancer unit, independent of the national screening programme, BreastCheck.
Aims: We hypothesised that patients attending symptomatic breast cancer units differ from national registry data and aimed to characterise this in a retrospective study.
Radiology
April 2020
From the Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, United Kingdom (N.A.H.); BreastCheck (The Irish National Breast Screening Program), Dublin, Ireland (A.O., M.K., G.H., C.S., H.F., M.M., N.P., F.F.); and Department of Radiology, Mater Misericordiae University Hospital, Dublin, Ireland (A.O., M.K., G.H., C.S., H.F., M.M., N.P., F.F.).
Background When there are discordant results between individual readers interpreting screening mammograms, consensus by independent readers may reduce unnecessary recalls for further work-up. Few studies have looked at consensus outcomes following the introduction of full-field digital mammography (FFDM). Purpose To determine outcomes of women discussed at consensus meetings during a 5-year period after introduction of FFDM, including recall rates, cancer detection, and interval cancers.
View Article and Find Full Text PDFPhys Med
January 2020
BreastCheck, National Screening Service, Eccles Unit, 36 Eccles St., Dublin 7, Ireland.
Purpose: Detector uniformity is an important parameter in digital mammography to guarantee a level of image quality adequate for early detection of breast cancer. Many problems with digital systems have been determined through the uniformity measurement, primarily as a result of incorrect flat-field calibration and artifacts caused by image receptor defects. The European guidelines suggest a method for the image uniformity assessment based on measurement of Signal-to-Noise ratio (SNR) and Pixel Value (PV) across a uniform image.
View Article and Find Full Text PDFBest Pract Res Clin Anaesthesiol
March 2019
Department of Anaesthesiology, BreastCheck & Cork University Hospital, Wilton Road, Cork, Ireland; Director Cork Academy of Regional Anaesthesia, Ground Floor, Tara House, Washington Street West, Cork, Ireland. Electronic address:
Ultrasound technology has transformed the practice of regional anaesthesia. Anaesthesiologists routinely use real-time images to guide needle and local anaesthetic placement adjacent to nerves. It is widely accepted that the era of ultrasonography has improved peripheral nerve block success rates and lessened the dose of local anaesthetic required to achieve success.
View Article and Find Full Text PDFBreast Cancer Res Treat
November 2018
Institute of Health & Society, Newcastle University, Richardson Road, Newcastle upon Tyne, NE2 4AX, UK.
Purpose: We examined whether demographic and tumour characteristics (including subtype) were different for women with breast cancer diagnosed via mammography screening compared with women with interval breast cancers, lapsed attenders of the screening programme and non-participants of the screening programme. In addition, we explored whether there were survival differences between the groups, taking into account lead time bias.
Methods: We used linked data from National Cancer Registry Ireland and the national breast screening programme BreastCheck.